glp 1 peptide microdose What Is Microdosing GLP-1s, and Is It Safe? Microdosing GLP-1s? Here's what doctors

With the participation of researchers from the Paul Langerhans Institute Dresden (PLID), partner at the German Center for Diabetes Research, a GLP-1 receptor agonist in the form of tablets could for the first time be compared with the most common second-line therapy of T2D, a DPP-IV inhibitor

As the popularity of GLP-1 drugs continues to skyrocket, there has also been a huge rise in overdoses

Data was sourced from the TriNetX research network, encompassing 101 hospital systems, and researchers identified two groups to analyze

Semaglutide & Tirzepatide injections with personalized treatment plans

Boasting about "no gym" when we know muscle loss is a problem with GLP-1s

Yesterday, the FDA published a reminder clarifying the status of compounded Tirzepatide now that the shortage for this GLP-1 product has been resolved.